ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,864Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 127

$1.31M Total Retail Price of All Prescriptions

Rank: 4 out of 127

623 Patients Receiving at Least One Drug in Part D
30%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 623 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

8% of this provider’s 623 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 2,627 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$111 was the average price of a prescription from this provider, compared to $132 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
RISPERIDONE 673 113 1 2
CITALOPRAM HBR 520 132 2 3
TRAZODONE HCL 425 34 3 1
MIRTAZAPINE 407 228 4 11
OLANZAPINE 368 116 5 13
DIVALPROEX SODIUM ER 360 176 6 21
CYMBALTA 335 104 7 8
OXCARBAZEPINE 325 0 8 31
ZOLPIDEM TARTRATE 315 82 9 4
ESCITALOPRAM OXALATE 262 116 10 18
QUETIAPINE FUMARATE 238 30 11 9
SERTRALINE HCL 230 64 12 6
HYDROXYZINE PAMOATE 225 11 R 13 14
TRIHEXYPHENIDYL HCL 218 18 R 14 29
HYDROCODONE-ACETAMINOPHEN 196 74 S3 15 60
LITHIUM CARBONATE 191 24 16 23
TOPIRAMATE 189 0 17 32
VENLAFAXINE HCL ER 181 28 18 17
ABILIFY 180 26 19 7
ZIPRASIDONE HCL 177 25 20 30
BENZTROPINE MESYLATE 171 0 R 21 12
NAMENDA 167 133 22 15
MELOXICAM 166 24 23 77
LAMOTRIGINE 165 13 24 5
SAPHRIS 165 12 10 24 88
HALOPERIDOL 158 19 26 34
BUPROPION XL 157 11 27 19
SIMVASTATIN 149 35 28 55
BUPROPION HCL SR 135 33 29 26
PAROXETINE HCL 131 30 30 22
OMEPRAZOLE 126 0 31 47
LISINOPRIL 121 47 32 49
PROPRANOLOL HCL 117 15 33 36
ROPINIROLE HCL 113 22 34 87
CLOZAPINE 107 0 35 25
FLUOXETINE HCL 103 11 36 10
METFORMIN HCL 101 0 37 58
GABAPENTIN 101 19 37 16
DONEPEZIL HCL 94 89 39 39
BUSPIRONE HCL 94 0 39 20
SEROQUEL XR 93 0 41 27
LEVOTHYROXINE SODIUM 90 34 42 43
SEROQUEL 89 11 43 33
FLUPHENAZINE HCL 84 13 44 50
DIVALPROEX SODIUM 77 53 45 24
FUROSEMIDE 76 21 46 67
NORTRIPTYLINE HCL 76 16 46 129
HYDROCHLOROTHIAZIDE 74 18 48 83
TRAMADOL HCL 73 0 49 57
CLOMIPRAMINE HCL 70 0 R 50 136
EXELON 67 52 51 72
GEODON 66 0 52 68
CARBAMAZEPINE 60 17 53 45
ALPRAZOLAM 58 19 54 117
LATUDA 58 0 54 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.